Allodynic Therapeutics, Inc. is a clinical-stage pharmaceutical company based in North Miami, FL, dedicated to developing a groundbreaking naltrexone-acetaminophen combination for the treatment of acute migraine and co-occurring anxiety. With completed clinical trials showcasing promising results in various pain conditions, the company is now embarking on a phase-2 clinical study specifically targeting acute migraines. The naltrexone-acetaminophen combination has the potential to revolutionize pain management by offering an effective alternative to opioids, which have limited efficacy and carry a high risk of addiction.
Generated from the website